Sandbox restrictive: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
! colspan="2" rowspan="3" |Disease | ! colspan="2" rowspan="3" |Disease | ||
! colspan="11" |Clinical manifestations | ! colspan="11" |Clinical manifestations | ||
! colspan=" | ! colspan="5" |Diagnosis | ||
|- | |- | ||
! colspan="4" |Symptoms | ! colspan="4" |Symptoms | ||
! colspan="7" |Physical exam | ! colspan="7" |Physical exam | ||
! rowspan="2" |Lab findings | ! rowspan="2" |Lab findings | ||
! colspan=" | ! colspan="3" |Imaging | ||
!Gold standard | !Gold standard | ||
|- | |- | ||
Line 24: | Line 24: | ||
!CXR | !CXR | ||
!CT | !CT | ||
!DLCco | |||
! | ! | ||
|- | |- | ||
Line 62: | Line 63: | ||
| | | | ||
* Bronchial dilatation within areas of ground-glass opacification | * Bronchial dilatation within areas of ground-glass opacification | ||
|''↓'' | |||
| | | | ||
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300 | |||
|- | |- | ||
| rowspan="2" |Bronchitis | | rowspan="2" |Bronchitis | ||
Line 90: | Line 93: | ||
| | | | ||
* N/A | * N/A | ||
|''↓'' | |||
| | | | ||
* Clinical diagnosis | * Clinical diagnosis | ||
Line 120: | Line 124: | ||
* Diaphragmatic flattening due to hyperinflation | * Diaphragmatic flattening due to hyperinflation | ||
* Increased retrosternal airspace on the lateral radiograph | * Increased retrosternal airspace on the lateral radiograph | ||
|N/A | | | ||
* N/A | |||
|<nowiki>-</nowiki> | |||
| | | | ||
|- | |- | ||
Line 161: | Line 167: | ||
* Occasionaly thin-walled cysts | * Occasionaly thin-walled cysts | ||
* Mild fibrotic changes | * Mild fibrotic changes | ||
|''↓'' | |||
| | | | ||
|- | |- | ||
| rowspan="4" |Pneumoconiosis | | rowspan="4" |Pneumoconiosis<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref> | ||
|SIlicosis | |SIlicosis<ref name="pmid16545629">{{cite journal |vauthors=du Bois RM |title=Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis |journal=Clin. Chest Med. |volume=27 |issue=1 Suppl 1 |pages=S17–25, v–vi |year=2006 |pmid=16545629 |doi=10.1016/j.ccm.2005.08.001 |url=}}</ref><ref name="pmid21996929">{{cite journal |vauthors=Neghab M, Mohraz MH, Hassanzadeh J |title=Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust |journal=J Occup Health |volume=53 |issue=6 |pages=432–8 |year=2011 |pmid=21996929 |doi= |url=}}</ref> | ||
| rowspan="4" | + | | rowspan="4" | + | ||
| rowspan="4" | + | | rowspan="4" | + | ||
Line 181: | Line 188: | ||
| rowspan="4" | + | | rowspan="4" | + | ||
| rowspan="4" | + | | rowspan="4" | + | ||
| - | | rowspan="4" | - | ||
| rowspan="4" | | | rowspan="4" | | ||
**Lungs are hyperresonant | **Lungs are hyperresonant | ||
Line 192: | Line 199: | ||
**[[Bronchophony]] present | **[[Bronchophony]] present | ||
**Increased [[tactile fremitus]]. | **Increased [[tactile fremitus]]. | ||
**Loud P2 | |||
| | | | ||
* Increased susceptiblity to tuberculosis. | * Increased susceptiblity to tuberculosis. | ||
| rowspan="4" | | | rowspan="4" | | ||
* | *Respiratory acidosis | ||
*Abnormal sputum | |||
*Abnormal sputum | |||
*CBC | *CBC | ||
** | **Anemia | ||
* | **Neutrophilia | ||
* | **Elevated ESR, | ||
**Elevated CRP | |||
** | **Elevated immunoglobulin | ||
* | |||
** | |||
| | | | ||
* Small round opacities | * Small round opacities | ||
Line 223: | Line 221: | ||
* Bullae, emphysema | * Bullae, emphysema | ||
* Pleural, mediastinal, and hilar changes | * Pleural, mediastinal, and hilar changes | ||
| | | rowspan="4" |''↓'' | ||
| rowspan="4" | | |||
* | * Lung biopsy | ||
|- | |- | ||
|Asbestosis | |Asbestosis | ||
| | | | ||
* Shipyard workers | |||
* Pipe fitting | |||
* Insulators | |||
| | | | ||
* Lung cancer | * Lung cancer | ||
Line 237: | Line 237: | ||
* Fine and coarse linear, peripheral, reticular opacities | * Fine and coarse linear, peripheral, reticular opacities | ||
| | | | ||
* Subpleural linear opacities seen parallel to the pleura | |||
* Basilar lung fibrosis | |||
* Peribronchiolar, intralobular, and interlobular septal fibrosis; | |||
* Honeycombing | |||
* Pleural plaques. | |||
|- | |- | ||
|Berylliosis | |Berylliosis | ||
| | | | ||
* Electronic manufactures | |||
| | | | ||
| | | | ||
* Hilar adenopathy | |||
* Increased interstitial markings. | |||
| | | | ||
* | * Ground glass opacification | ||
* | * Parenchymal nodules | ||
* | * Septal lines | ||
|- | |- | ||
|Byssinosis | |Byssinosis | ||
| | | | ||
* Cotton wool workers | |||
| | | | ||
* Increased susceptibility to ''Actinomyces'' and ''Aspergillus'' infection. | |||
| | | | ||
* Diffuse air-space consolidation | |||
| | | | ||
* Pulmonary fibrosis with honeycombing | |||
* Peri bronchovascular distribution of nodules | |||
* Ground-glass attenuations | |||
|- | |- | ||
| | | colspan="2" |Sarcodiosis | ||
| | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
* African Americans | |||
* Autoimmune | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | | | ||
* Usually normal | |||
* Crackles may be audible | |||
| | | | ||
* Dermatologic manifestations | |||
* Ocular involvement | |||
* Osseous involvement | |||
* Heart failure from cardiomyopathy | |||
* Lymphocytic meningitis | |||
* Cranial nerve palsies | |||
| | | | ||
* Hypercalcemia or hypercalciuria | |||
* Elevated 1, 25-dihydroxyvitamin D levels | |||
* Elevated angiotensin-converting enzyme (ACE) | |||
| | | | ||
* Bilateral hilar lymphadenopathy | |||
| | | | ||
* High-resolution CT (HRCT) scanning of the chest may identify | |||
** Active alveolitis | |||
** Fibrosis | |||
|''↓'' | |||
| | | | ||
* Biopsy | |||
** Non-caseating granuolma | |||
|- | |- | ||
| | | colspan="2" |Pleural Effusion | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|'''Transudate''' | |||
* Congestive heart failure | |||
* Cirrhosis (hepatic hydrothorax) | |||
* Atelectasis (may be due to occult malignancy or pulmonary embolism) | |||
* Hypoalbuminemia | |||
* Nephrotic syndrome | |||
'''Exudate''' | |||
* Parapneumonic causes | |||
* Malignancy (most commonly lung or breast cancer, lymphoma, and leukemia; less commonly ovarian carcinoma, stomach cancer, sarcomas, melanoma) | |||
* Pulmonary embolism | |||
* Collagen-vascular conditions (rheumatoid arthritis, systemic lupus erythematosus | |||
* Tuberculosis (TB) | |||
* Pancreatitis | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
|<nowiki>+/-</nowiki> | |||
| | | | ||
* Dullness to percussion | |||
* Decreased tactile fremitus, | |||
* Asymmetrical chest expansion, | |||
* Diminished or delayed expansion on the side of the effusion: | |||
* Diminished or inaudible breath sounds | |||
* Pleural friction rub | |||
| | | | ||
* Peripheral edema, distended neck veins, and S<sub>3</sub> gallop suggest congestive heart failure. | |||
* Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome. | |||
* Cutaneous changes and ascites suggest liver disease. | |||
* Lymphadenopathy or a palpable mass suggests malignancy. | |||
| | | | ||
* Thoracentesis | |||
** Exudate | |||
** Transudate | |||
** LDH, Glucose, cytology | |||
* Other specific labs of underlying etiology | |||
|Supine | |||
* Blunting of the costophrenic angle | |||
* Homogenous increase in density spread over the lower lung fields | |||
Lateral decubitus | |||
* Free flowing effusion as layers | |||
| | | | ||
* Thickened pleura | |||
* Mild effusions can aslo be detected | |||
|''↓'' | |||
| | | | ||
* Thoracocentesis | |||
|- | |||
| rowspan="4" |Neuromuscular disease | |||
|Scoliosis | |||
| - | |||
| + | |||
| - | |||
| - | |||
| | | | ||
* Postural abnormality | |||
| - | |||
| - | |||
| - | |||
| - | |||
| | | | ||
* Decreased breathe sounds | |||
| | | | ||
* In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe. | |||
| | | | ||
* R/0 genetic conditions | |||
** Marfan's syndrome | |||
** Edward's syndrome | |||
* Total lymphocyte count (should be >1500/μL) | |||
* Nutritional status must be assessed | |||
| | | | ||
* Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs | |||
| | | | ||
* N/A | |||
| | | | ||
| | | | ||
* Clinical | |||
* Radiographs | |||
|- | |- | ||
| | |Muscular dystrophy | ||
| | |<nowiki>-</nowiki> | ||
| | |<nowiki>+</nowiki> | ||
| | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |||
| | | | ||
* Proximal muscle weakness (shoulder and pelvic girdle) | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| - | |||
| | | | ||
* Decreased breathe sounds | |||
* Decreased chest expansion | |||
| | | | ||
* Rash | |||
| | | | ||
* Elevated CPK and aldolase | |||
* +ANA | |||
* +Anti-Jo abs | |||
* Elevated ESR, CRP and RF | |||
| | | | ||
* N/A | |||
| | | | ||
* N/A | |||
| | | | ||
| | | | ||
* Muscle biopsy | |||
|- | |||
|ALS | |||
|<nowiki>-</nowiki> | |||
|<nowiki>+</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | | | ||
* Muscle weakness | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
|<nowiki>-</nowiki> | |||
| | | | ||
* Decreased breathe sounds | |||
* Decreased chest expansion | |||
| | | | ||
* Symptoms begin with limb involvement diue to muscle weakness and atrophy. | |||
* Cognitive or behavioral dysfunction | |||
* Sensory nerves and the autonomic nervous system are generally unaffected | |||
|N/A | |||
|Not significant/diagnostic | |||
|Not significant/diagnostic | |||
|<nowiki>-</nowiki> | |||
| | | | ||
* Clinical diagnosis | |||
* Nerve conduction studies and needle electromyography (EMG) | |||
|- | |- | ||
| | |Myasthenia gravis | ||
| | | - | ||
| | | + | ||
| | | - | ||
| | | + | ||
| | |H/O of difficulty getting up from chair | ||
| | * Combing | ||
| | |||
| | * Difficulty in swallowing | ||
| - | |||
| - | |||
| - | |||
| - | |||
| | | | ||
* Decreased breathe sounds | |||
* Decreased chest expansion | |||
| | | | ||
* Extraocular, bulbar, or proximal limb muscles. | |||
* Breathing as rapid and shallow, | |||
* Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation. | |||
| | | | ||
* Anti–acetylcholine receptor (AChR) antibody (Ab) test + | |||
* | |||
| | | | ||
* Thymoma as an anterior mediastinal mass. | |||
| | | | ||
* Thymoma as an anterior mediastinal mass. | |||
| | | | ||
| | | | ||
* Electromyography | |||
|- | |- | ||
| | |Interstitial (Nonidiopathic) Pulmonary Fibrosis | ||
| | | | ||
| + | |||
| ++ | |||
| + | |||
| - | |||
| | | | ||
* Connective-tissue disorder | |||
* Pneumoconiosis | |||
| + | |||
| + | |||
| + | |||
| + | |||
| | | | ||
* Wheezing | |||
* S3 | |||
* P2 | |||
* End-inspiratory rales | |||
| | | | ||
* Increased A-a gradient | |||
| | | | ||
* Elevated ESR | |||
* Serologic testing for ANA, RF, ANCA & ASCA may be positive | |||
| | | | ||
* Reticular and/or nodular opacities | |||
* Honeycomb appearance (late finding) | |||
| | | | ||
* Bilateral reticular and nodular interstitial infiltrates | |||
|''↓'' | |||
|Video-assisted thoracoscopic lung biopsy | |||
|- | |- | ||
| | |Lymphocytic Interstitial Pneumonia | ||
| | | | ||
| + | |||
| + | |||
| + | |||
| + | |||
| | | | ||
* Autoimmune | |||
* Lymphoproliferative disorders | |||
| - | |||
| + | |||
| - | |||
| - | |||
| | | | ||
* Wheezing | |||
* Rales | |||
| | | | ||
* Increased A-a gradient | |||
| | | | ||
* Polyclonal hypergammaglobulinemia | |||
* Increased LDH | |||
| | | | ||
* Bibasilar interstitial or micronodular infiltrates | |||
| | | | ||
* Determines the degree of fibrosis | |||
* Cysts (characterstic) | |||
|N | |||
|Open lung biopsy | |||
|- | |- | ||
| | |Obesity | ||
| | | | ||
| + | |||
| + | |||
| - | |||
| - | |||
| | | | ||
* Overweight | |||
* Diabetes mellitus | |||
* Asthma | |||
| - | |||
| - | |||
| - | |||
| + | |||
| | | | ||
* Wheezing | |||
| | | | ||
| | | | ||
* Increased hematocrit | |||
| | | | ||
* X ray findings are often limited due to body habitus | |||
| | | | ||
* CT findings are variable and depends upon severity of obesity | |||
|N | |||
|Clinical | |||
|- | |- | ||
| | |Pulmonary Eosinophilia | ||
| | | | ||
| + | |||
| + | |||
| + | |||
| + | |||
|Infections | |||
* Prasitic | |||
* Fungal | |||
* Mycobacterial | |||
| + | |||
| - | |||
| + | |||
| + | |||
| | | | ||
* Wheezing | |||
* Rales | |||
| | | | ||
* Increased A-a gradient | |||
| | | | ||
* Leukocytosis with eosinophilia (> 250/µL) | |||
| | | | ||
* Interstitial or diffuse nodular densities | |||
| | | | ||
* Determines extent and distribution of the disease | |||
* Interstitial infiltrates | |||
* Cysts and nodules | |||
|''↓'' | |||
|Biopsy of lesion (skin or lung) | |||
|} | |} | ||
<references /> |
Latest revision as of 14:33, 20 February 2018
Disease | Clinical manifestations | Diagnosis | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical exam | Lab findings | Imaging | Gold standard | |||||||||||||
Cough | Dyspnea | Hemoptysis | Fever | History/Exposure | Cyanosis | Clubbing | JVD | Peripheral edema | Auscultation | Other prominent findings | CXR | CT | DLCco | ||||
Acute Respiratory Distress Syndrome (ARDS) | - | + | - | - | Inciting event, such as: | + | - | - | - |
|
|
|
|
|
↓ |
| |
Bronchitis | Acute | + | - | +/- | + | - | - | - | - | - |
|
|
|
↓ |
| ||
Chronic | + | + | - | - |
|
+ | - | + | + |
|
|
|
- | ||||
Hypersensitivity Pneumonitis | + | + | - | + |
|
- | + | - | - |
|
|
|
|
|
↓ | ||
Pneumoconiosis[1] | SIlicosis[2][3] | + | + | +/- | - |
|
+ | + | + | - |
|
|
|
|
|
↓ |
|
Asbestosis |
|
|
|
| |||||||||||||
Berylliosis |
|
|
| ||||||||||||||
Byssinosis |
|
|
|
| |||||||||||||
Sarcodiosis | + | + | + | + |
|
- | - | - | - |
|
|
|
|
|
↓ |
| |
Pleural Effusion | + | + | +/- | +/- | Transudate
Exudate
|
+/- | +/- | +/- | +/- |
|
|
|
Supine
Lateral decubitus
|
|
↓ |
| |
Neuromuscular disease | Scoliosis | - | + | - | - |
|
- | - | - | - |
|
|
|
|
|
| |
Muscular dystrophy | - | + | - | - |
|
- | - | - | - |
|
|
|
|
|
| ||
ALS | - | + | - | - |
|
- | - | - | - |
|
|
N/A | Not significant/diagnostic | Not significant/diagnostic | - |
| |
Myasthenia gravis | - | + | - | + | H/O of difficulty getting up from chair
|
- | - | - | - |
|
|
|
|
|
| ||
Interstitial (Nonidiopathic) Pulmonary Fibrosis | + | ++ | + | - |
|
+ | + | + | + |
|
|
|
|
|
↓ | Video-assisted thoracoscopic lung biopsy | |
Lymphocytic Interstitial Pneumonia | + | + | + | + |
|
- | + | - | - |
|
|
|
|
|
N | Open lung biopsy | |
Obesity | + | + | - | - |
|
- | - | - | + |
|
|
|
|
N | Clinical | ||
Pulmonary Eosinophilia | + | + | + | + | Infections
|
+ | - | + | + |
|
|
|
|
|
↓ | Biopsy of lesion (skin or lung) |
- ↑ Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ (1998). "Idiopathic pulmonary fibrosis: predicting response to therapy and survival". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1063–72. doi:10.1164/ajrccm.157.4.9703022. PMID 9563720.
- ↑ du Bois RM (2006). "Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis". Clin. Chest Med. 27 (1 Suppl 1): S17–25, v–vi. doi:10.1016/j.ccm.2005.08.001. PMID 16545629.
- ↑ Neghab M, Mohraz MH, Hassanzadeh J (2011). "Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust". J Occup Health. 53 (6): 432–8. PMID 21996929.